Overview

  • Product nameAnti-MDA5 antibody
    See all MDA5 primary antibodies
  • Description
    Mouse monoclonal to MDA5
  • Tested applicationsSuitable for: ELISA, IHC-P, Sandwich ELISAmore details
  • Species reactivity
    Reacts with: Human
  • Immunogen

    Recombinant fragment, corresponding to amino acids 929-1024 of Human MDA5 with proprietary tag (NP_071451).

  • Positive control
    • Human placenta tissue.

Properties

Associated products

Applications

Our Abpromise guarantee covers the use of ab118377 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

Application Abreviews Notes
ELISA Use at an assay dependent concentration.
IHC-P Use a concentration of 3 µg/ml.
Sandwich ELISA Use a concentration of 10 µg/ml.

Target

  • FunctionRNA helicase that, through its ATP-dependent unwinding of RNA, may function to promote message degradation by specific RNases. Seems to have growth suppressive properties. Involved in innate immune defense against viruses. Upon interaction with intracellular dsRNA produced during viral replication, triggers a transduction cascade involving MAVS/IPS1, which results in the activation of NF-kappa-B, IRF3 and IRF7 and the induction of the expression of antiviral cytokines such as IFN-beta and RANTES (CCL5). ATPase activity is specifically induced by dsRNA. Essential for the production of interferons in response to picornaviruses.
  • Tissue specificityWidely expressed, at a low level. Expression is detected at slightly highest levels in placenta, pancreas and spleen and at barely levels in detectable brain, testis and lung.
  • Involvement in diseaseGenetic variation in IFIH1 is associated with diabetes mellitus insulin-dependent type 19 (IDDM19) [MIM:610155]. A multifactorial disorder of glucose homeostasis that is characterized by susceptibility to ketoacidosis in the absence of insulin therapy. Clinical fetaures are polydipsia, polyphagia and polyuria which result from hyperglycemia-induced osmotic diuresis and secondary thirst. These derangements result in long-term complications that affect the eyes, kidneys, nerves, and blood vessels.
    Note=IFIH1 is the CADM-140 autoantigen, involved in clinically amyopathic dermatomyositis (CADM). This is a chronic inflammatory disorder that shows typical skin manifestations of dermatomyositis but has no or little evidence of clinical myositis. Anti-CADM-140 antibodies appear to be specific to dermatomyositis, especially CADM. Patients with anti-CADM-140 antibodies frequently develop life-threatening acute progressive interstitial lung disease (ILD).
  • Sequence similaritiesBelongs to the helicase family.
    Contains 2 CARD domains.
    Contains 1 helicase ATP-binding domain.
    Contains 1 helicase C-terminal domain.
  • Post-translational
    modifications
    During apoptosis, processed into 3 cleavage products. The helicase-containing fragment, once liberated from the CARD domains, translocate from the cytoplasm to the nucleus. The processed protein significantly sensitizes cells to DNA degradation.
  • Cellular localizationCytoplasm. Nucleus. May be found in the nucleus, during apoptosis.
  • Information by UniProt
  • Database links
  • Alternative names
    • CADM-140 autoantigen antibody
    • Clinically amyopathic dermatomyositis autoantigen 140 kDa antibody
    • DEAD/H (Asp Glu Ala Asp/His) box polypeptide antibody
    • DEAD/H box polypeptide antibody
    • Helicard antibody
    • Helicase with 2 CARD domains antibody
    • Hlcd antibody
    • IDDM 19 antibody
    • IDDM19 antibody
    • IFIH 1 antibody
    • Ifih1 antibody
    • IFIH1_HUMAN antibody
    • Interferon induced helicase C domain containing protein 1 antibody
    • interferon induced with helicase C domain 1 antibody
    • Interferon induced with helicase C domain protein 1 antibody
    • Interferon-induced helicase C domain-containing protein 1 antibody
    • Interferon-induced with helicase C domain protein 1 antibody
    • MDA 5 antibody
    • MDA-5 antibody
    • Melanoma differentiation associated protein 5 antibody
    • Melanoma differentiation-associated gene 5 antibody
    • Melanoma differentiation-associated protein 5 antibody
    • MGC133047 antibody
    • Murabutide down regulated protein antibody
    • Murabutide down-regulated protein antibody
    • RH 116 antibody
    • RH116 antibody
    • RIG I like receptor 2 antibody
    • RLR 2 antibody
    • RNA helicase DEAD box protein 116 antibody
    • RNA helicase-DEAD box protein 116 antibody
    see all

Anti-MDA5 antibody images

  • ab118377, at 3ug/ml, staining MDA5 in Formalin-fixed, Paraffin-embedded Human Placenta tissue by Immunohistochemistry.
  • Detection limit for recombinant tagged MDA5 is 3 ng/ml as a capture antibody.

References for Anti-MDA5 antibody (ab118377)

ab118377 has not yet been referenced specifically in any publications.

Product Wall

There are currently no Abreviews or Questions for ab118377.
Please use the links above to contact us or submit feedback about this product.

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"